Breaking News Instant updates and real-time market news.

NICE

Nice

$128.59

2.06 (1.63%)

13:25
04/16/19
04/16
13:25
04/16/19
13:25

Nice Systems to host investor day

Investor day to be held in Las Vegas on April 16 at 2:15 pm. Webcast Link

  • 16

    Apr

  • 16

    Apr

NICE Nice
$128.59

2.06 (1.63%)

03/29/19
JEFF
03/29/19
NO CHANGE
Target $134
JEFF
Buy
Nice Systems can hit $2B in sales before five year goal, says Jefferies
Jefferies analyst John DiFucci maintains a Buy rating on Nice Systems with a $134 price target after hosting investor meetings with management. The analyst believes the company can exceed the $2B revenue market sooner than its goal of five years. Given the rising cloud revenue mix and the nature of the cloud customer engagement business model, Nice's reported metrics "understate the company's true, underlying momentum," DiFucci tells investors in a research note.
03/28/19
JPMS
03/28/19
NO CHANGE
Target $63
JPMS
Overweight
Verint price target raised to $63 from $59 at JPMorgan
JPMorgan analyst Paul Coster raised his price target for Verint Systems (VRNT) to $63 from $59 and reiterates an Overweight rating on the shares. The company's Q4 results came in above expectations and its commentary remains "very upbeat," largely owing to cloud acceleration as well as traction with the "land and expand" strategy within Customer Engagement and visibility from large cyber projects, Coster tells investors in a research note. The analyst favors shares of Verint over near-peer Nice Systems (NICE). He reiterates an Overweight rating on the former "with conviction."
02/15/19
WEDB
02/15/19
NO CHANGE
Target $145
WEDB
Outperform
Nice Systems price target raised to $145 from $130 at Wedbush
Wedbush analyst Daniel Ives maintained an Outperfom rating on Nice Systems and raised his price target to $145 after company reported earnings that were "solid across the board," beating the Street on almost every metric. Ives tells investors in a research note that he is increasingly confident in the company's ability to execute its strategy in the field over the next 12-18 months on an expanding TAM.
02/15/19
JEFF
02/15/19
NO CHANGE
Target $134
JEFF
Buy
Nice Systems remains a top mid-cap pick at Jefferies
Jefferies analyst John DiFucci says Nice Systems exceeded Q4 expectations on most metrics with very strong Cloud results, though guidance was mixed. "Muddying matters are the unclear disclosures" from the company surrounding ASC 606 impacts as the company transitions its non-GAAP financials to the standard, DiFucci tells investors in a post-earnings research note. The analyst, however, continues to believe that the business has "strong momentum and a large opportunity in front of it that management is executing well against." Nice remains DiFucci's top mid-cap pick and he boosted his price target for the shares to $134 from $132 while maintaining a Buy rating.

TODAY'S FREE FLY STORIES

HESM

Hess Midstream Partners

$22.89

0.09 (0.39%)

08:00
04/25/19
04/25
08:00
04/25/19
08:00
Hot Stocks
Hess Midstream Partners plans to expand natural gas processing capacity »

Hess Midstream Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 08

    May

HAS

Hasbro

$103.18

2.84 (2.83%)

08:00
04/25/19
04/25
08:00
04/25/19
08:00
Downgrade
Hasbro rating change  »

Hasbro downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    May

  • 29

    May

08:00
04/25/19
04/25
08:00
04/25/19
08:00
General news
U.S. initial jobless claims preview: »

U.S. initial jobless…

NMCI

Navios Maritime Containers

$2.24

(0.00%)

07:58
04/25/19
04/25
07:58
04/25/19
07:58
Hot Stocks
Navios Maritime Containers announces delivery of one containership »

Navios Maritime…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LRCX

Lam Research

$195.40

0.56 (0.29%)

07:56
04/25/19
04/25
07:56
04/25/19
07:56
Recommendations
Lam Research analyst commentary at Citi »

Citi ups target on top…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

TSLA

Tesla

$258.70

-5.15 (-1.95%)

07:55
04/25/19
04/25
07:55
04/25/19
07:55
Downgrade
Tesla rating change  »

Tesla downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSFT

Microsoft

$125.00

-0.5 (-0.40%)

07:55
04/25/19
04/25
07:55
04/25/19
07:55
Recommendations
Microsoft analyst commentary at BMO Capital »

Microsoft price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 03

    Jun

  • 03

    Jun

  • 08

    Jun

  • 10

    Jun

  • 23

    Jun

  • 06

    Aug

VBIV

VBI Vaccines

$2.00

(0.00%)

07:55
04/25/19
04/25
07:55
04/25/19
07:55
Conference/Events
VBI Vaccines to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 10

    May

  • 23

    May

UBSI

United Bankshares

$38.81

0.03 (0.08%)

07:53
04/25/19
04/25
07:53
04/25/19
07:53
Earnings
United Bankshares reports Q1 EPS 62c, consensus 61c »

Reports Q1 book value per…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 15

    May

HBAN

Huntington Bancshares

$13.75

-0.04 (-0.29%)

07:53
04/25/19
04/25
07:53
04/25/19
07:53
Hot Stocks
Huntington Bancshares reaffirms three-year target of 4%-6% revenue growth »

For 2019, sees FY19…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 30

    May

  • 31

    May

  • 29

    Aug

APC

Anadarko

$71.41

7.29 (11.37%)

, OXY

Occidental Petroleum

$62.00

-0.35 (-0.56%)

07:52
04/25/19
04/25
07:52
04/25/19
07:52
Downgrade
Anadarko, Occidental Petroleum, Chevron rating change at Jefferies »

Jefferies downgrades…

APC

Anadarko

$71.41

7.29 (11.37%)

OXY

Occidental Petroleum

$62.00

-0.35 (-0.56%)

CVX

Chevron

$118.31

-3.69 (-3.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 28

    Apr

  • 30

    Apr

  • 07

    May

  • 10

    May

  • 14

    May

  • 22

    May

  • 29

    May

MTSI

Macom

$15.86

-0.33 (-2.04%)

07:51
04/25/19
04/25
07:51
04/25/19
07:51
Downgrade
Macom rating change  »

Macom downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    May

ABBV

AbbVie

$78.71

0.06 (0.08%)

07:49
04/25/19
04/25
07:49
04/25/19
07:49
Hot Stocks
AbbVie reports Q1 global hematologic oncology portfolio revenue $1.173B »

Global net revenues from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 28

    Apr

  • 03

    May

  • 03

    May

  • 04

    May

  • 18

    May

  • 31

    May

  • 05

    Jun

APC

Anadarko

$71.41

7.29 (11.37%)

, OXY

Occidental Petroleum

$62.00

-0.35 (-0.56%)

07:48
04/25/19
04/25
07:48
04/25/19
07:48
Recommendations
Anadarko, Occidental Petroleum, Chevron analyst commentary at Morgan Stanley »

Strategic value of…

APC

Anadarko

$71.41

7.29 (11.37%)

OXY

Occidental Petroleum

$62.00

-0.35 (-0.56%)

CVX

Chevron

$118.31

-3.69 (-3.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 28

    Apr

  • 30

    Apr

  • 07

    May

  • 10

    May

  • 14

    May

  • 22

    May

  • 29

    May

PTC

PTC

$101.94

1.12 (1.11%)

07:48
04/25/19
04/25
07:48
04/25/19
07:48
Downgrade
PTC rating change  »

PTC downgraded to Neutral…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NXGN

NextGen Healthcare

$17.65

0.38 (2.20%)

07:47
04/25/19
04/25
07:47
04/25/19
07:47
Upgrade
NextGen Healthcare rating change  »

NextGen Healthcare…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

ABBV

AbbVie

$78.71

0.06 (0.08%)

07:47
04/25/19
04/25
07:47
04/25/19
07:47
Hot Stocks
AbbVie CEO says 'we are off to another excellent start' »

"We are off to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 28

    Apr

  • 03

    May

  • 03

    May

  • 04

    May

  • 18

    May

  • 31

    May

  • 05

    Jun

ABBV

AbbVie

$78.71

0.06 (0.08%)

07:46
04/25/19
04/25
07:46
04/25/19
07:46
Hot Stocks
AbbVie reports Q1 U.S. HUMIRA sales of $3.215B up 7.1% »

IInternationally, HUMIRA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 28

    Apr

  • 03

    May

  • 03

    May

  • 04

    May

  • 18

    May

  • 31

    May

  • 05

    Jun

AZPN

Aspen Technology

$114.55

2.435 (2.17%)

07:45
04/25/19
04/25
07:45
04/25/19
07:45
Upgrade
Aspen Technology rating change  »

Aspen Technology upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

07:45
04/25/19
04/25
07:45
04/25/19
07:45
General news
Treasury Market Outlook: bond markets are mixed »

Treasury Market Outlook:…

XLNX

Xilinx

$139.79

2.66 (1.94%)

07:44
04/25/19
04/25
07:44
04/25/19
07:44
Downgrade
Xilinx rating change at Needham »

Xilinx downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    May

CIGI

Colliers International

$69.14

-0.39 (-0.56%)

07:44
04/25/19
04/25
07:44
04/25/19
07:44
Hot Stocks
Colliers International acquires affiliate in Sweden »

Colliers International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 05

    Jun

ABBV

AbbVie

$78.71

0.06 (0.08%)

07:43
04/25/19
04/25
07:43
04/25/19
07:43
Earnings
AbbVie raises FY19 adj. EPS view to $8.73-$8.83 from $8.65-$8.75 »

FY19 consensus $8.69. The…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 28

    Apr

  • 03

    May

  • 03

    May

  • 04

    May

  • 18

    May

  • 31

    May

  • 05

    Jun

HAS

Hasbro

$103.18

2.84 (2.83%)

07:42
04/25/19
04/25
07:42
04/25/19
07:42
Downgrade
Hasbro rating change at Argus »

Hasbro downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    May

  • 29

    May

WAB

Wabtec

$76.57

-0.19 (-0.25%)

, GE

General Electric

$9.32

-0.025 (-0.27%)

07:42
04/25/19
04/25
07:42
04/25/19
07:42
Hot Stocks
Wabtec CEO Ray Betler to retire, Rafael Santana to succeed »

Wabtec (WAB) announced…

WAB

Wabtec

$76.57

-0.19 (-0.25%)

GE

General Electric

$9.32

-0.025 (-0.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 30

    Apr

  • 08

    May

  • 08

    May

  • 21

    May

  • 29

    May

  • 05

    Jun

  • 05

    Jun

  • 13

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.